113 related articles for article (PubMed ID: 11672913)
1. Lack of contact transmission of recombinant Marek's disease virus type 1 expressing the fusion protein of Newcastle disease virus.
Okamura H; Sakaguchi M; Yokogawa K; Tokunaga E; Abe S; Tokiyoshi S; Mizuno K
Vaccine; 2001 Nov; 20(3-4):483-9. PubMed ID: 11672913
[TBL] [Abstract][Full Text] [Related]
2. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
[TBL] [Abstract][Full Text] [Related]
3. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
[TBL] [Abstract][Full Text] [Related]
4. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two strains of Marek's disease virus serotype 1 for the development of recombinant vaccines against very virulent infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Gao Y; Zhang Y; Cui H; Qi X; Zhong L; Wang X
Antiviral Res; 2017 Mar; 139():153-160. PubMed ID: 27908832
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
[TBL] [Abstract][Full Text] [Related]
8. Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.
Sakaguchi M; Hirayama Y; Maeda H; Matsuo K; Yamamoto M; Hirai K
Vaccine; 1994 Aug; 12(10):953-7. PubMed ID: 7975837
[TBL] [Abstract][Full Text] [Related]
9. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
[TBL] [Abstract][Full Text] [Related]
10. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
[TBL] [Abstract][Full Text] [Related]
11. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
[TBL] [Abstract][Full Text] [Related]
12. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
13. Marek's disease virus protein kinase gene identified within the short unique region of the viral genome is not essential for viral replication in cell culture and vaccine-induced immunity in chickens.
Sakaguchi M; Urakawa T; Hirayama Y; Miki N; Yamamoto M; Zhu GS; Hirai K
Virology; 1993 Jul; 195(1):140-8. PubMed ID: 8391181
[TBL] [Abstract][Full Text] [Related]
14. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
[TBL] [Abstract][Full Text] [Related]
15. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
16. Viral kinetics, shedding profile, and transmission of serotype 1 Marek's disease vaccine Rispens/CVI988 in maternal antibody-free chickens.
Islam T; Renz KG; Walkden-Brown SW; Ralapanawe S
Avian Dis; 2013 Jun; 57(2 Suppl):454-63. PubMed ID: 23901761
[TBL] [Abstract][Full Text] [Related]
17. Polyvalent recombinant Marek's disease virus vaccine against poultry diseases.
Hirai K; Sakaguchi M
Curr Top Microbiol Immunol; 2001; 255():261-87. PubMed ID: 11217427
[No Abstract] [Full Text] [Related]
18. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
King DJ
Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
[TBL] [Abstract][Full Text] [Related]
19. Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease.
Sonoda K; Sakaguchi M; Matsuo K; Zhu GS; Hirai K
Vaccine; 1996 Mar; 14(4):277-84. PubMed ID: 8744553
[TBL] [Abstract][Full Text] [Related]
20. Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek's disease virus.
Lee LE; Witter RL; Reddy SM; Wu P; Yanagida N; Yoshida S
Avian Dis; 2003; 47(3):549-58. PubMed ID: 14562881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
